Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe most immediate side effects of Wegovy are gastrointestinal — nausea, stomach discomfort, and sometimes diarrhoea or constipation — and they tend to arrive within the first 24 to 48 hours after your first injection. They are common, usually mild, and for most people they settle within days rather than weeks. Wegovy (semaglutide) is a prescription-only medicine, and a prescriber will review your full health picture before it is suitable for you. If you are reading this before your first dose, or because something unexpected has happened since your injection, both are completely understandable reasons to want clear information.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
For the majority of people starting Wegovy, the earliest signs that something is happening are digestive. Nausea is the most common, reported by a significant proportion of participants across the clinical trial programme. It can feel like a low-grade queasiness after meals, or something stronger if you eat a large or fatty portion. Alongside nausea, loose stools or constipation, bloating, burping, and indigestion are all recognised Wegovy immediate side effects, and you can read about all side effects of Wegovy as listed in the patient information leaflet and confirmed on the NHS medicines page for semaglutide.
The starting dose of Wegovy (0.25 mg) is set deliberately low to give your system time to adapt. Even so, some people notice their appetite drops sharply from the first injection, which can itself contribute to lightheadedness or tiredness if they undereat. Headache and mild fatigue are also reported early on. These are not signs that something has gone wrong; they are signs that the medicine is doing something.
Practical things that genuinely help in the first day or two: smaller meals, avoiding very rich or fried food, staying well hydrated, and not lying down immediately after eating. These are not a substitute for guidance from your prescriber, but they are consistent with NHS advice on managing GI effects during treatment.
Side effects that calmed down after your first few doses can resurface each time the dose is increased. That is not unusual. The jump from one dose level to the next asks your body to adjust again, so a fresh wave of nausea or digestive unsettledness in the first day or two after a new pen is not a sign that Wegovy has stopped suiting you. It is worth knowing this in advance, because patients who are not expecting it sometimes worry they are having a new adverse reaction.
If you are restarting Wegovy after a break, the same pattern applies: the immediate side effects of returning to treatment can feel much like starting fresh, particularly if your prescriber steps you back to a lower dose first.
The side effects most likely to be noticeable immediately after a dose increase mirror those from the first injection: nausea, loose stools, stomach heaviness, and reduced appetite. They tend to be short-lived. Persistent symptoms (lasting more than a week after a dose change) are worth flagging with your prescriber or our support team.
Most Wegovy immediate side effects are uncomfortable rather than dangerous. A small number of reactions require prompt attention. Knowing the difference matters.
Seek urgent medical help if you experience severe stomach pain that does not ease, particularly if it spreads towards your back, this is one of the warning signs of acute pancreatitis, which the MHRA highlighted in a Drug Safety Update for GLP-1 medicines in January 2026 as an infrequent but serious risk. Urgent attention is also needed for signs of a serious allergic reaction (swelling of the face, lips or throat, difficulty breathing, a widespread rash), symptoms of gallbladder problems (pain in the upper right abdomen, fever, yellowing skin), or severe vomiting and diarrhoea that you cannot keep fluids down from, as dehydration can affect kidney function.
A fast or noticeably irregular heartbeat after starting Wegovy is less commonly discussed but worth knowing about, our guide on Wegovy and heart rate covers what the evidence shows and when it needs clinical review. If you are uncertain whether a symptom needs same-day attention, contact NHS 111 or your GP. For any suspected side effect you want to flag formally, the Yellow Card scheme is open to patients and carers directly.
Beyond the immediate picture, there is a broader profile of effects that can develop over weeks rather than hours. Our Wegovy side effects guide covers those in more detail, including what is listed as common, uncommon, and rare in the prescribing information. For those wanting to understand the more serious end of the spectrum, this page on Wegovy's more serious side effects sets out the warning signs clearly without exaggerating their frequency.
The clinical breakdown of each side effect of Wegovy is one of the first things our prescribers discuss when assessing suitability. Your medical history, existing medications, and any previous GI conditions all affect how Wegovy is likely to feel for you personally. No two people's experience is identical. If you want to talk through what to expect before committing to treatment, starting a free consultation is the natural next step, a real prescriber reads your answers, not software, and can give you an honest picture based on your own health profile. You can also read about our clinical team on this page.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.